Oral Statins and Protection From Hearing Loss

PHASE4RecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

February 9, 2023

Primary Completion Date

October 1, 2025

Study Completion Date

December 31, 2025

Conditions
Sudden Sensorineural Hearing Loss
Interventions
DRUG

Statin

Oral dose to be taken with methylprednisolone

DRUG

methylprednisolone

oral dose, standard of care

DRUG

dexamethasone

Drug for intratympanic administration

DRUG

Placebo

Capsule the same as for statins but without statin

Trial Locations (1)

60611

RECRUITING

Northwestern Memorial Hospital, Chicago

All Listed Sponsors
lead

Northwestern University

OTHER